High-grade acute organ toxicity as a positive prognostic factor in primary radiochemotherapy for anal carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1467-1478

  Wolff, Hendrik Andreas ^a   Raus, Ismene ^a   Jung, Klaus ^a   Schüler, Phillip ^a   Herrmann, Markus Karl ^a   Hennies, Steffen ^a   Vorwerk, Hilke ^a   Hille, Andrea ^a   Hess, Clemens Friedrich ^a   Christiansen, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Anal carcinoma; Prognostic factor; Radiochemotherapy; Toxicity

Indexed keywords

5-FLUOROURACIL; ANAL CARCINOMA; BIO-MOLECULAR; BODY SURFACE; CLINICAL TRIAL; INGUINAL LYMPH NODES; LOCOREGIONAL CONTROL; MITOMYCIN C; MULTI VARIATE ANALYSIS; NORMAL TISSUE; OVERALL SURVIVAL; OVERALL SURVIVAL RATES; PATIENT POPULATION; PROGNOSTIC FACTOR; PROGNOSTIC FACTORS; RADIOCHEMOTHERAPY; SKIN REACTION; TREATMENT OUTCOMES; TREATMENT RESPONSE; TUMOR TISSUES;

CHEMOTHERAPY; DISEASES; MULTIVARIANT ANALYSIS; POPULATION STATISTICS; TEMPERATURE CONTROL; TOXICITY;

PATIENT TREATMENT;

FLUOROURACIL; MITOMYCIN C;

ACUTE TOXICITY; ADULT; AGED; ANEMIA; ANUS CARCINOMA; ARTICLE; BLADDER FISTULA; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CYSTITIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DYSURIA; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; INGUINAL LYMPH NODE; LEUKOPENIA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE SPASM; MYOCARDIAL DISEASE; ORGAN INJURY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT COMPLIANCE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROCTITIS; PROGNOSIS; RADIATION DOSE; RECTOVAGINAL FISTULA; RECTUM FISTULA; SKIN FIBROSIS; SKIN TOXICITY; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; CYSTITIS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; ENTERITIS; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROCTITIS; PROGNOSIS; RADIODERMATITIS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 79952696991     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.010     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Haddock MG, Martenson JA Jr., Anal carcinoma. Cancer Treat Res 1998;98:201-225.
3. Daling JR, Weiss NS, Klopfenstein LL, et al. Correlates of homosexual behavior and the incidence of anal cancer. JAMA 1982;247:1988-1990. (Pubitemid 12133712)
4. Melbye M, Cote TR, Kessler L, et al. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994;343:636-639. (Pubitemid 24087808)
5. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000;7:147-156. (Pubitemid 30196783)
6. Hoots BE, Palefsky JM, Pimenta JM, et al. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009;124:2375-2383.
7. Das P, Crane CH, Ajani JA. Current treatment for localized anal carcinoma. Curr Opin Oncol 2007;19:396-400. (Pubitemid 46883533)
8. Nigro ND, Seydel HG, Considine B, et al. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983;51:1826-1829. (Pubitemid 13093950)
9. UK Coordinating Committee on Cancer Research and UKCCCR Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 1996;348:1049-1054.
10. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 1997;15:2040-2049. (Pubitemid 27209535)
11. Flam M, John M, Pajak TF, et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 1996;14:2527-2539. (Pubitemid 26300120)
12. Chao C, Goldberg M, Hoffman JP. Surgical salvage therapy: Abdominoperineal resection for recurrent anal carcinoma, metastasectomy of recurrent colorectal cancer, and esophagectomy after combined chemoradiation. Curr Opin Oncol 2000;12:353-356. (Pubitemid 32043973)
13. Patel UA, Thakkar KH, Holloway N. Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital. Laryngoscope 2008;118:428-432. (Pubitemid 351640614)
14. Bonner JAHP, Giralt J, Cohen R, Baselga J, Raben D, Shin DM, Ove R, Jassem J, Amellal N, Azarnia N, Ang KK. The relationship of cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab. Int J Radiat Oncol Biol Phys 2005;63:1.
15. Cuzick J, Sestak I, Cella D, et al. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: A retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143-1148.
16. Kuhnt T, Richter C, Enke H, et al. Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy. Strahlenther Onkol 1998;174:257-261. (Pubitemid 28237139)
17. Sobin LH, Wittekind C. TNM classification of malignant tumours. 6th ed. New York: Wiley-Liss; 2002.
18. Chavaudra J. [Last ICRU recommendations for the prescription, recording and reporting of external bean therapy]. Cancer Radiother 1998;2:607-614.
19. Trotti A, Byhardt R, Stetz J, et al. Common toxicity criteria version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:13-47. (Pubitemid 30179675)
20. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
21. Trotti A, Colevas AD, Setser A, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176-181. (Pubitemid 36962641)
22. Rubin P, Constine LS III, Fajardo LF, et al. for the EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 1995;35:9-10.
23. Hendry JH, Jeremic B, Zubizarreta EH. Normal tissue complications after radiation therapy. Rev Panam Salud Publica 2006;20:151-160. (Pubitemid 44916093)
24. Dahl O, Horn A, Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 1994;33:409-413.
25. Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007;68:794-800. (Pubitemid 46818735)
26. Roohipour R, Patil S, Goodman KA, et al. Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome. Dis Colon Rectum 2008;51:147-153.
27. Grabenbauer GG, Kessler H, Matzel KE, et al. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: Long-term results of 101 patients. Dis Colon Rectum 2005;48:1742-1751. (Pubitemid 41243129)
28. Nguyen WD, Mitchell KM, Beck DE. Risk factors associated with requiring a stoma for the management of anal cancer. Dis Colon Rectum 2004;47:843-846. (Pubitemid 38702603)
29. Bilimoria KY, Bentrem DJ, Rock CE, et al. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: Analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009;52:624-631.
30. Christiansen H, Hermann RM, Hille A, et al. Concomitant radiochemotherapy in primary inoperable advanced head and neck cancer with 5-fluorouracil and mitomycin-C. Head Neck 2004;26:845-853. (Pubitemid 39299303)
31. Daly T, Poulsen MG, Denham JW, et al. The effect of anaemia on efficacy and normal tissue toxicity following radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Radiother Oncol 2003;68:113-122. (Pubitemid 38367543)
32. Dietz A, Rudat V, Conradt C, et al. [Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas]. HNO 2000;48:655-664.
33. Fein DA, Lee WR, Hanlon AL, et al. Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx. J Clin Oncol 1995;13:2077-2083.
34. Grant DG, Hussain A, Hurman D. Pre-treatment anaemia alters outcome in early squamous cell carcinoma of the larynx treated by radical radiotherapy. J Laryngol Otol 1999;113:829-833. (Pubitemid 29433702)
35. Rades D, Stoehr M, Meyners T, et al. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo) therapy for locally advanced head-and-neck cancer. Strahlenther Onkol 2008;184:198-205. (Pubitemid 351508132)
36. Pradier O, Lederer K, Hille A, et al. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: A phase II trial with special reference to the hemoglobin level as prognostic parameter. J Cancer Res Clin Oncol 2005;131:261-269. (Pubitemid 40238943)
37. Dellas K, Bache M, Pigorsch SU, et al. Prognostic impact of HIF-1alpha expression in patients with definitive radiotherapy for cervical cancer. Strahlenther Onkol 2008;184:169-174. (Pubitemid 351365780)
38. Haydaroglu A, Yurut V, Arican A, et al. The impact of the haemoglobin level on the response to radiotherapy. J BUON 2002;7:31-34. (Pubitemid 34464172)
39. Gervaz P, Buchs N, Morel P. Diagnosis and management of anal cancer. Curr Gastroenterol Rep 2008;10:502-506.
40. Wong S, Gibbs P, Chao M, et al. Carcinoma of the anal canal: a local experience and review of the literature. ANZ J Surg 2004;74:541-546. (Pubitemid 39006074)
41. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol 2004;5:149-157. (Pubitemid 38262846)